Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma
Autor: | Shuang Bai, Tong-Mei Zhang, Ying-Bin Yan, Wei Chen, Hao Liu, Yuan-Yuan Tian, Ping Zhang |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Framingham Risk Score Article Subject business.industry lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease Lower risk lcsh:RC254-282 Head and neck squamous-cell carcinoma Genome Gene expression profiling 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Germline mutation 030220 oncology & carcinogenesis Internal medicine medicine Copy-number variation Oral Cavity Squamous Cell Carcinoma business Research Article |
Zdroj: | Journal of Oncology Journal of Oncology, Vol 2019 (2019) |
ISSN: | 1687-8469 1687-8450 |
DOI: | 10.1155/2019/3865279 |
Popis: | High-throughput gene expression profiling has recently emerged as a promising technique that provides insight into cancer subtype classification and improved prediction of prognoses. Immune/inflammatory-related mRNAs may potentially enrich genes to allow researchers to better illustrate cancer microenvironments. Oral cavity squamous cell carcinoma (OC-SCC) exhibits high morbidity and poor prognosis compared to that of other types of head and neck squamous cell carcinoma (HNSCC), and these differences may be partially due to differences within the tumor microenvironments. Based on this, we designed an immune-related signature to improve the prognostic prediction of OC-SCC. A cohort of 314 OC-SCC samples possessing whole genome expression data that were sourced from The Cancer Genome Atlas (TCGA) database was included for discovery. The GSE41613 database was used for validation. A risk score was established using immune/inflammatory signatures acquired from the training dataset. Principal components analysis, GO analysis, and gene set enrichment analysis were used to explore the bioinformatic implications. When grouped by the dichotomized risk score based on the signature, this classifier could successfully discriminate patients with distinct prognoses within the training and validation cohorts (P<0.05 in both cohorts) and within different clinicopathological subgroups. Similar somatic mutation patterns were observed between high and low risk score groups, and different copy number variation patterns were also identified. Further bioinformatic analyses suggested that the lower risk score group was significantly correlated with immune/inflammatory-related biological processes, while the higher risk score group was highly associated with cell cycle-related processes. The analysis indicated that the risk score was a robust predictor of patient survival, and its functional annotation was well established. Therefore, this bioinformatic-based immune-related signature suggested that the microenvironment of OC-SCC could distinguish among patients with different underlying biological processes and clinical outcomes, and the use of this signature may shed light on future OC-SCC classification and therapeutic design. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |